Menu
Not yet recruiting NCT07502911

The Effect of Women's Heart Health Awareness Program

No phase Interventional Cardiovascular Health Cardiovascular Risk Factors Health Literacy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Heart Health Awareness Program.
Who it may be relevant to
Registry conditions: Cardiovascular Health, Cardiovascular Risk Factors, Health Literacy. Basic parameters: 20 years — 64 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of a Heart Health Awareness Program on Women's Knowledge, Attitudes, and Practice Toward Cardiovascular Disease and Health Literacy: A Single-Blind Cluster Randomized Controlled Trial

Overview

The aim of this study is to examine the effect of a gender-specific heart health protection awareness program, incorporating video-supported reminder messages, on knowledge, attitudes, practices (KAP) regarding cardiovascular diseases and health literacy among adult women aged 20 to 64 with no prior diagnosis of cardiovascular disease. The centers where the study is conducted will be divided into intervention (n=4) and control (n=5) groups using cluster randomization. While the intervention group receives a heart health awareness program consisting of three sessions in total, including education, risk factor screening, and individual counseling over a period of three weeks, the control group will receive standard of care. Data will be collected at the beginning of the first session and after the completion of the final session.

Interventions

  • Behavioral Heart Health Awareness Program
    Intervention group participants will receive a 3-week program focused on cardiovascular diseases prevention, consisting of 45-minute weekly sessions. The first two sessions are educational sessions involving visual presentations, Q\&A, and discussions, with informative brochures provided. To reinforce learning, six reminder video messages will be sent via WhatsApp every two days post-educational sessions. The final session includes a CVD risk screening (height, weight, BMI, waist circumference,

Primary outcome measures

  • Change in knowledge sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention. [Time frame: Baseline (Week 0) and at the end of the 3-week intervention period]
  • Change in attitude sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention [Time frame: Baseline (Week 0) and at the end of the 3-week intervention period]
  • Change in physical activity behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention [Time frame: Baseline (Week 0) and at the end of the 3-week intervention period]
  • Change in diet and smoking behavior behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention [Time frame: Baseline (Week 0) and at the end of the 3-week intervention period]
Secondary outcome measures (1)
  • Change in Health Literacy Scale-Short Form scores from baseline to post-intervention [Time frame: Baseline (Week 0) and at the end of the 3-week intervention period]

Eligibility criteria

Inclusion criteria

  • Being female,
  • Aged between 20 and 64 years (inclusive),
  • Being literate,
  • Regularly attending any course at the Family Center,
  • Active user of the WhatsApp application.

Exclusion criteria

  • Being an immigrant with a Turkish language barrier (unable to communicate in Turkish),
  • Being pregnant,
  • Being in the postpartum period,
  • Having a prior diagnosis of any cardiovascular disease,
  • Having a prior diagnosis of any type of cancer.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

Turkey (Türkiye) · 1 center
  • Lokman Hekim Universty — Ankara

Identifiers

NCT: NCT07502911 · LokmanHekimU-Hem-NO-03

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗